Series C funding round for CANbridge Pharmaceuticals raising $38M in July 2018
Series C funding round for CANbridge Pharmaceuticals raising $38M in July 2018
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$214M
Top Valuation
-
CANbridge Pharmaceuticals raised $38M in a Series C round.
The round was announced on 07/01/18.